Tags : Zealand Pharma

Weekly Snapshot

PharmaShots Weekly Snapshot (February 10-14, 2020)

1. Epizyme Reports the US FDA Acceptance of NDA for Tazverik (tazemetostat) to Treat Follicular Lymphoma Published: Feb 14, 2020 | Tags: Epizyme, Reports, US, FDA, Acceptance, NDA, Tazverik, tazemetostat, Follicular Lymphoma 2. Soligenix’s RiVax Receives the US FDA’s Fast Track Designation for the Prevention of Ricin Poisoning Published: Feb 13, 2020 | Tags: Soligenix, RiVax, Receives, […]Read More

M&A

Zealand Pharma to Acquire Valeritas’ Business and Retain its Employees

Shots: Valeritas to sell all its business to Zealand, in an all-cash transaction of ~$23M. Zealand will continue Valeritas’ commercially-focused operations and retain nearly all its employees For the smooth accomplishment of a transaction, Valeritas and its subsidiaries filed voluntary petitions for relief under Chapter 11 of the US bankruptcy code in the court. The […]Read More

Weekly Snapshot

PharmaShots Weekly Snapshot (September 02 – 06, 2019)

1.Roche’s Tecentriq + Chemotherapy Receives EC’s Approval as 1L Treatment for Extensive Stage Small Cell Lung Cancer Published: Sept 06, 2019 | Tags: Roche, Tecentriq, Chemotherapy, Receives, EC, Approval, Initial Treatment, Extensive Stage Small Cell Lung Cancer 2. OncoCyte to Acquire Razor Genomics for the Expansion of its Capabilities in Early-Stage Lung Cancer Published: Sept 05, 2019 […]Read More